Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Tenchusatsu who wrote (211431)	11/11/2004 4:25:51 AM
From: Joe NYC	Respond to of 1577989

Tenchusatsu, Drug companies will react by not selling to Canada anymore. We'll end up back at square one, except with a bigger public outcry against those "evil" drug companies. They could sell for US prices, or they could cut US prices a bit, and increase foreign prices to the same level. Anyway, there is another problem, which is price of IP. The cost of drug is sum of the manufacturing costs and cost of IP. Manufacturing costs need to be paid by everyone, but is it "fair" or practical to charge the same amount for IP in China and the US? Microsoft is trying to figure this out, and is coming out with ways to cut prices for foreigners, in order not to lose market share. It is easier to do it with "localized" version of software (in certain language). It is more difficult for drug companies. Joe